BACKGROUND: This study investigates the association between diagnostic delay (total delay), quality of life (QoL) and patient satisfaction, and the associations between QoL and patient satisfaction scores and survival for women diagnosed with ovarian or endometrial cancer. METHODS: A questionnaire survey was conducted among 723 women diagnosed with ovarian or endometrial cancer from 2006 to 2007; 453 women were chosen to participate in the study. Data on total delay (number of weeks between first cancer symptom and initiation of treatment) were available from 353 women. RESULTS: Experiencing longer total delay was associated with reduced overall QoL and appetite loss among ovarian cancer patients, while longer total delay was associated with reduced overall QoL, reduced role and social functioning, and increased fatigue, insomnia and constipation among endometrial cancer patients. Likewise, longer total delay was associated with decreased patient satisfaction for both cancer types. For survival and QoL scores, worse scores for pain were statistically significantly associated with reduced survival for women diagnosed with ovarian cancer, while reduced overall QoL, physical, role and emotional functioning as well as increased nausea and vomiting, pain, dyspnoea and appetite loss were associated with reduced survival for women diagnosed with endometrial cancer. For survival and patient satisfaction, associations were not significant when adjusted for diagnosis, age, cancer stage and radicality of operation. CONCLUSIONS: We found that few QoL measures were associated with total delay and survival for ovarian cancer, while a number of associations were found between QoL, total delay and survival for endometrial cancer patients. This supports the hypothesis that long total delay may influence QoL and survival for some cancer patients. Reduced patient satisfaction with the diagnostic phase was also statistically significantly associated with long total delay, highlighting that total delay is an important component in patients' evaluation of the care they receive.
BACKGROUND: This study investigates the association between diagnostic delay (total delay), quality of life (QoL) and patient satisfaction, and the associations between QoL and patient satisfaction scores and survival for women diagnosed with ovarian or endometrial cancer. METHODS: A questionnaire survey was conducted among 723 women diagnosed with ovarian or endometrial cancer from 2006 to 2007; 453 women were chosen to participate in the study. Data on total delay (number of weeks between first cancer symptom and initiation of treatment) were available from 353 women. RESULTS: Experiencing longer total delay was associated with reduced overall QoL and appetite loss among ovarian cancerpatients, while longer total delay was associated with reduced overall QoL, reduced role and social functioning, and increased fatigue, insomnia and constipation among endometrial cancerpatients. Likewise, longer total delay was associated with decreased patient satisfaction for both cancer types. For survival and QoL scores, worse scores for pain were statistically significantly associated with reduced survival for women diagnosed with ovarian cancer, while reduced overall QoL, physical, role and emotional functioning as well as increased nausea and vomiting, pain, dyspnoea and appetite loss were associated with reduced survival for women diagnosed with endometrial cancer. For survival and patient satisfaction, associations were not significant when adjusted for diagnosis, age, cancer stage and radicality of operation. CONCLUSIONS: We found that few QoL measures were associated with total delay and survival for ovarian cancer, while a number of associations were found between QoL, total delay and survival for endometrial cancerpatients. This supports the hypothesis that long total delay may influence QoL and survival for some cancerpatients. Reduced patient satisfaction with the diagnostic phase was also statistically significantly associated with long total delay, highlighting that total delay is an important component in patients' evaluation of the care they receive.
Authors: Simon C Crawford; Jonathan A Davis; Nadeem A Siddiqui; Linda de Caestecker; Charles R Gillis; David Hole; Gillian Penney Journal: BMJ Date: 2002-07-27
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: Allison J Love; Pascal Lambert; Donna Turner; Robert Lotocki; Erin Dean; Shaundra Popowich; Alon D Altman; Mark W Nachtigal Journal: CMAJ Open Date: 2017-02-07
Authors: Lindsey A Jones; Carol Estwing Ferrans; Blase N Polite; Katherine C Brewer; Ajay V Maker; Heather A Pauls; Garth H Rauscher Journal: Ann Epidemiol Date: 2017-10-13 Impact factor: 3.797
Authors: Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer Journal: Health Technol Assess Date: 2020-11 Impact factor: 4.014
Authors: Chioma O Erondu; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Edward Peters; Ann G Schwartz; Paul D Terry; Kristin Wallace; Lucy Akushevich; Frances Wang; Sydnee Crankshaw; Andrew Berchuck; Joellen M Schildkraut; Patricia G Moorman Journal: J Womens Health (Larchmt) Date: 2016-02-17 Impact factor: 2.681
Authors: Yang Zhou; Melinda L Irwin; Leah M Ferrucci; Ruth McCorkle; Elizabeth A Ercolano; Fangyong Li; Kevin Stein; Brenda Cartmel Journal: Gynecol Oncol Date: 2016-04-19 Impact factor: 5.482